Table 4.
group | VD insufficiency (<20 ng/mL) |
Non-VD insufficiency (≥20 ng/mL) |
OR | p |
---|---|---|---|---|
NAFLD patients | ||||
FLI <60 n (%) | 165 (65.7) | 86 (34.3) | 1.307 (0.924-1.848) | 0.129 |
FLI ≥60 n (%) | 46 (74.2) | 16 (25.8) | 1.959 (1.061-3.616) | 0.030 |
NAFLD patients | ||||
NFS <-1.455 n (%) | 192 (68.3) | 89 (31.7) | 1.470 (1.047-2.064) | 0.026 |
NFS ≥-1.455 n (%) | 19 (59.4) | 13 (40.6) | 0.996 (0.474-2.090) | 0.991 |
NAFLD patients | ||||
FIB-4 <1.3 n (%) | 177 (70.8) | 73 (29.2) | 1.652 (1.158-2.357) | 0.005 |
FIB-4 ≥1.3 n (%) | 34 (54.0) | 29 (46.0) | 0.799 (0.463-1.378) | 0.419 |
Control | 182 (59.5) | 124 (40.5) | Reference | – |
NFS, NAFLD fibrosis score; FIB-4, Fibrosis 4 Score; FLI, fatty liver index.